Key result
Cardiac co-overexpression of PP2C and PP5 in double transgenic mice was detrimental to cardiac function, reducing basal ejection fraction by 38% and significantly increasing markers of hypertrophy, fibrosis, and inflammation compared to wild-type mice.
Why the study?
PP5 and PP2C occur in the human heart, but how they interact remains unclear.
Cardiac co-overexpression of PP2C and PP5 in mice is detrimental to cardiac function, leading to reduced ejection fraction, fibrosis, and inflammation.
The function importance of serine threonine phosphatases (PP) in the heart is still subject of investigations. For instance, PP5 and PP2C occur in the human heart. It is unclear how they interact in the human heart. In order to obtain a model system, we have crossbred mice with heart-specific overexpression of PP2C or PP5 to obtain wild-type mice (WT), PP2C transgenic mice (PP2C-TG), PP5 transgenic mice (PP5-TG), and PP2CxPP5 double transgenic mice (DT). Moreover, while PP2C-TG and PP5-TG did not show any increase in relative heart weight, it was increased in DT. In histology, DT showed cardiac fibrosis based on Masson/Goldner staining compared to WT. Basal ejection fraction was reduced in PP5-TG by 25%, by 29% in PP2C-TG, and by 38% of WT values in DT. This went hand in hand with a diminished phosphorylation of phospholamban at serine-16, the phosphorylation site for the cAMP-dependent protein kinase (PKA), after perfusion of isolated hearts with isoprenaline. DT and PP2C-TG sustained ischemia and reperfusion of isolated hearts worse than WT or PP5-TG. Expression of atrial natriuretic factor (ANF, marker of hypertrophy), of collagen 1a (fibrosis marker) and nuclear factor kappa B (marker of inflammation) in DT were augmented versus WT (ANF: 5.14 ± 0.75 vs. 1.00 ± 0.33; Col1a1: 1.82 ± 0.09 vs. 1.00 ± 0.10; Nfkb1: 1.33 ± 0.03 vs 1.00 ± 0.04; n = 6–10; p < 0.05). In summary, cardiac co-overexpression of two PPs, namely, PP2C and PP5, was detrimental to cardiac function. The underlying (patho)mechanism for this may involve dephosphorylation of Ca 2+ regulatory proteins but also accompanying fibrosis and inflammation.
No takes yet. Share an insight, caveat, or question.
Schwarz et al. (2026) studied Systolic heart failure. Cardiac co-overexpression of PP2C and PP5 (double transgenic) vs. Wild-type mice was evaluated on Expression of atrial natriuretic factor (ANF, marker of hypertrophy) (p=<0.05). Cardiac co-overexpression of PP2C and PP5 in double transgenic mice was detrimental to cardiac function, reducing basal ejection fraction by 38% and significantly increasing markers of hypertrophy, fibrosis, and inflammation compared to wild-type mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: